1 enrolling by invitation. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Enrolling by invitation 1 |
Follow ctDNA: new trials by email Literature Review of ctDNA trials Research Report on ctDNA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy Step-up therapy, Standard treatment Routine treatment - Esophageal Cancer, MRD | Early Phase 1 | Enrolling by invitation | The First Affiliated Hospital with Nanjing Medical University | 65 | 2025-12-20 | 2026-01-27 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)
PMID 25691612, PMID 33538338, PMID 35708168, PMID 36990609, PMID 40115982, PMID 40914168